Biomea Fusion, Inc.

NasdaqGS:BMEA Stock Report

Market Cap: US$135.2m

Biomea Fusion Management

Management criteria checks 2/4

Biomea Fusion's CEO is Thomas Butler, appointed in Aug 2017, has a tenure of 7.42 years. total yearly compensation is $2.71M, comprised of 22.5% salary and 77.5% bonuses, including company stock and options. directly owns 6.88% of the company’s shares, worth $9.30M. The average tenure of the management team and the board of directors is 3.8 years and 3.1 years respectively.

Key information

Thomas Butler

Chief executive officer

US$2.7m

Total compensation

CEO salary percentage22.5%
CEO tenure7.4yrs
CEO ownership6.9%
Management average tenure3.8yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

Sep 30
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Jun 10
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth

Feb 22
We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth

Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?

Nov 07
Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?

We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Jul 12
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

Mar 29
Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely

Nov 03
We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely

Biomea Fusion GAAP EPS of -$0.59 beats by $0.01

Aug 01

We're Not Very Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

Jul 20
We're Not Very Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate

Biomea Fusion (NASDAQ:BMEA) Is In A Good Position To Deliver On Growth Plans

Mar 16
Biomea Fusion (NASDAQ:BMEA) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

Nov 27
Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation

Biomea Fusion: Patience Warranted

Sep 23

CEO Compensation Analysis

How has Thomas Butler's remuneration changed compared to Biomea Fusion's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$144m

Jun 30 2024n/an/a

-US$140m

Mar 31 2024n/an/a

-US$127m

Dec 31 2023US$3mUS$609k

-US$117m

Sep 30 2023n/an/a

-US$108m

Jun 30 2023n/an/a

-US$102m

Mar 31 2023n/an/a

-US$95m

Dec 31 2022US$921kUS$583k

-US$82m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$61m

Mar 31 2022n/an/a

-US$52m

Dec 31 2021US$7mUS$552k

-US$42m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$2mUS$229k

-US$5m

Compensation vs Market: Thomas's total compensation ($USD2.71M) is above average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.

CEO

Thomas Butler (43 yo)

7.4yrs

Tenure

US$2,707,310

Compensation

Mr. Thomas Butler co-founded Biomea Fusion, Inc in August 2017 and has been its Chief Executive Officer and Director since August 2017. He serves as the Chairman of Biomea Fusion, Inc. He serves as a Manag...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Butler
Co-Founder7.4yrsUS$2.71m6.88%
$ 9.3m
Ramses Erdtmann
Co-Founder7.4yrsno data5.66%
$ 7.7m
Franco Valle
CFO & Principal Accounting Officer3.5yrsUS$1.30m0.12%
$ 160.4k
Juan Frias
Chief Medical Officer1.4yrsUS$4.17m0.00096%
$ 1.3k
Heow Tan
Chief Technology & Quality Officer4.2yrsno datano data
Naomi Cretcher
Chief People Officerno datano datano data
Thorsten Kirschberg
Executive Vice President of Chemistry4.3yrsno datano data
Stephan Morris
Chief Development Officer2.9yrsno datano data
Ravi Upasani
Executive Vice President of Intellectual Property3.8yrsno datano data
Caroline Perez- Dupont
Senior Vice President of Contractsless than a yearno datano data
Alex Cacovean
Vice President of Clinical Development & Clinical Sciencesno datano datano data

3.8yrs

Average Tenure

54yo

Average Age

Experienced Management: BMEA's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Thomas Butler
Co-Founder7.4yrsUS$2.71m6.88%
$ 9.3m
Ramses Erdtmann
Co-Founder7.4yrsno data5.66%
$ 7.7m
Eric Aguiar
Independent Lead Director4.1yrsUS$254.80k0%
$ 0
Juliana Chan
Member of Scientific Advisory Boardless than a yearno datano data
Elizabeth Faust
Independent Director2.6yrsUS$221.99k0%
$ 0
Bihua Chen
Independent Director4.1yrsUS$228.80k0%
$ 0
Sumita Ray
Independent Director3.6yrsUS$235.30k0%
$ 0
Julio Rosenstock
Member of Scientific Advisory Boardless than a yearno datano data
Michael J. Hitchcock
Independent Director3.8yrsUS$241.30k0.041%
$ 55.9k
Jeremy Pettus
Member of Scientific Advisory Boardless than a yearno datano data
Rohit Kulkarni
Member of Scientific Advisory Boardless than a yearno datano data
Freddy Eliaschewitz
Member of Scientific Advisory Boardless than a yearno datano data

3.1yrs

Average Tenure

59yo

Average Age

Experienced Board: BMEA's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 06:15
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biomea Fusion, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter LawsonBarclays
Naureen QuibriaCapital One Securities, Inc.
Yigal NochomovitzCitigroup Inc